[1]
|
Miyoshi, N., Wagatsuma, H., Wakana, S., et al. (2000) Identification of an Imprinted Gene. Meg3/Gtl2 and Its Human Homologne MEG3, First Mapped on Mouse Distal Chromosome 12 and Human Chromosome 14q. Genes to Cells, 5, 211-220. https://doi.org/10.1046/j.1365-2443.2000.00320.x
|
[2]
|
Zhang, X., Zhou, Y., Mehta, K.R., et al. (2003) A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells. Journal of Clinical Endocrinology and Metabolism, 88, 5119-5126.
https://doi.org/10.1210/jc.2003-030222
|
[3]
|
Gejman, R., Batista, D.L., Zhong, Y., et al. (2008) Selective Loss of MEG3 Expression and Intergenic Differentially Methylated Region Hypermethylation in the MEG3/DLKl Locus in Human Clinically Nonfunctioning Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism, 93, 4119-4125. https://doi.org/10.1210/jc.2007-2633
|
[4]
|
Wilusz, J.E., Sunwoo, H. and Spector, D.L. (2009) Long Noncoding RNAs: Functional Surprises from the RNA World. Genes & Development, 23, 1494-1504. https://doi.org/10.1101/gad.1800909
|
[5]
|
Nagano, T. and Fraser, P. (2011) No-Nonsense Functions for Long Noncoding RNAs. Cell, 145, 178-181.
https://doi.org/10.1016/j.cell.2011.03.014
|
[6]
|
Tsang, W.P. Timothy, W.L., Albert, H.H., et al. (2007) Induction of Drug Resistance and Transformation in Human Cancer. RNA, 13, 890-898. https://doi.org/10.1261/rna.359007
|
[7]
|
Ponting, C.P., Oliver, P.L. and Reik, W. (2009) Evolution and Functions of Long Noncoding RNAs. Cell, 136, 629-641. https://doi.org/10.1016/j.cell.2009.02.006
|
[8]
|
Rinn, J.L., Kertesz, M., Wang, J.K., et al. (2007) Functional Demarcation of Active and Silent Chromatin Domains in Human HOX loci By noncoding RNAs. Cell, 129, 1311-1323. https://doi.org/10.1016/j.cell.2007.05.022
|
[9]
|
Khalil, A.M., Guttman, M., Huarte, M., et al. (2009) Many Human Large Intergenic Noncoding RNAs Associate with Chromatin-Modifying Complexes and Affect Gene Expression. Proceedings of the National Academy of Sciences of the United States of America, 106, 667-672. https://doi.org/10.1073/pnas.0904715106
|
[10]
|
Gupta, R.A., Shan, N., Wang, K.C., et al. (2010) Long Non-Coding RNA HOTAIR Reprograms Chromatin State to Promote Cancer Metastasis. Nature, 464, 1071-1076. https://doi.org/10.1038/nature08975
|
[11]
|
Schmidt, L.H., Spieker, T., Koschmieder, S., et al. (2011) The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-Small Cell Lung Cancer and Induces Migration and Tumor Growth. Journal of Thoracic Oncology, 6, 1984-1992. https://doi.org/10.1097/JTO.0b013e3182307eac
|
[12]
|
Menon, A.G., Rutter, J.L., von Sattel, J.P., et al. (1997) Frequent Loss of Chromosome 14 in Atypical and Malignant Meningioma: Identification of a Putative “Tumor Pro-gression” Locus. Oncogene, 14, 611-616.
https://doi.org/10.1038/sj.onc.1200853
|
[13]
|
Mutirangura, A., Pornthanakasem, W., Sriuranpong, V., et al. (1998) Loss of Heterozygosity on Chromosome 14 in Nasopharyngeal Carcinoma. International Journal of Cancer, 78, 153-156.
https://doi.org/10.1002/(SICI)1097-0215(19981005)78:2<153::AID-IJC5>3.0.CO;2-Y
|
[14]
|
Bando, T., Kato, Y., Ihara, Y., et al. (1999) Loss of Heterozygosity of 14q32 in Colorectal Carcinoma. Cancer Genetics and Cytogenetics, 111, 161-165. https://doi.org/10.1016/S0165-4608(98)00242-8
|
[15]
|
Itoyama, T., Chaganti, R.S., Yamada, Y., et al. (2001) Cytogenetic Analysis and Clinical Significance in Adult T-Cell Leukemia/Lymphoma: A Study of 50 Cases from the Human T-Cell Leukemia Virus Type-1 Endemic Area, Nagasaki. Blood, 97, 3612-3620. https://doi.org/10.1182/blood.V97.11.3612
|
[16]
|
Seitz, H., Royo, H., Bortolin, M.L., et al. (2004) A Large Imprinted microRNA Gene Cluster at the Mouse Dlk1-Gtl2 Domain. Genome Research, 14, 1741-1748. https://doi.org/10.1101/gr.2743304
|
[17]
|
Zhou, Y., Zhong, Y., Wang, Y., et al. (2007) Activation of p53 by MEG3 Non-Coding RNA. The Journal of Biological Chemistry, 282, 24731-24742. https://doi.org/10.1074/jbc.M702029200
|
[18]
|
Zhang, X., Rice, K., Wang, Y., Chen, W., Zhong, Y., Nakayama, Y., Zhou, Y. and Klibanski, A. (2010) Maternally Expressed Gene 3 (MEG3) Noncoding Ribonucleic Acid: Isoform Structure, Expression, and Functions. Endocrinology, 151, 939-947. https://doi.org/10.1210/en.2009-0657
|
[19]
|
Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K.A., Zhou, Y., Cheunsuchon, P., Louis, D.N. and Klibanski, A. (2010) Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression. Cancer Research, 70, 2350-2358.
|
[20]
|
Wang, P.J., Ren, Z.Q. and Sun, P.Y. (2012) Overexpression of the Long Non-Coding RNA MEG3 Impairs in Vitro Glioma Cell Proliferation. Journal of Cellular Biochemistry, 113, 1868-1874.
|
[21]
|
Harris, S.L. and Levine, A.J. (2005) The p53 Pathway: Positive and Negative Feedback Loops. Oncogenem, 24, 2899-2908. https://doi.org/10.1038/sj.onc.1208615
|
[22]
|
Zhao, J., Dahle, D., Zhou, Y., Zhang, X. and Klibanski, A. (2005) Hypermethylation of the Promoter Region Is Associated with the Loss of MEG3 Gene Expression in Human Pituitary Tumors. Journal of Clinical Endocrinology and Metabolism, 90, 2179-2186. https://doi.org/10.1210/jc.2004-1848
|
[23]
|
Kagami, M., O’Sullivan, M.J., Green, A.J., Watabe, Y., Arisaka, O., Masawa, N., Matsuoka, K., Fukami, M., Matsubara, K., Kato, F., et al. (2010) The IG-DMR and the MEG3-DMR at Human Chromosome 14q32.2: Hierarchical Interaction and Distinct Functional Properties as Imprinting Control Centers. PLoS Genetics, 6, e1000992.
https://doi.org/10.1371/journal.pgen.1000992
|
[24]
|
Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C.M. and Patel, T. (2011) microRNA-29 Can Regulate Expression of the Long Non-Coding RNA Gene MEG3 in Hepatocellular Cancer. Oncogene, 30, 4750-4756. https://doi.org/10.1038/onc.2011.193
|
[25]
|
Morenoc, S., Evansc, O., Zhan, X., et al. (2005) Novel Molecular Signaling and Classification of Human Clinically Non-Functional Pituitary Adenomas Identified by Gene Expression Profiling and Proteomic Analyses. Cancer Research, 65, 10214-10222. https://doi.org/10.1158/0008-5472.CAN-05-0884
|
[26]
|
Losa, M., Franzin, A., Mangilif, et al. (2000) Proliferation Index of Nonfunctioning Pituitary Adenomas: Correlations with Clinical Characteristics and Long-Term Follow-Up Results. Neurosurgery, 47, 1313-1319.
|
[27]
|
Louis, D.N., Wiestler, O.D. and Cavenee, W.K. (2007) World Health Organization Classification of Tumours of the Central Nervous System. IARC Press, Lyon.
|
[28]
|
Bo, J., Yang, G., Huo, K., Jiang, H., Zhang, L., Liu, D. and Huang, Y. (2011) microRNA-203 Suppresses Bladder Cancer Development by Repressing bcl-w Expression. The FEBS Journal, 278, 786-792.
https://doi.org/10.1111/j.1742-4658.2010.07997.x
|
[29]
|
Kim, E.J., Lee, Y.S., Kim, Y.J., Kim, M.J., Ha, Y.S., Jeong, P., Lee, O.J. and Kim, W.J. (2010) Clinical Implications and Prognostic Values of Topoisomerase-II Alpha Expression in Primary Non-Muscle-Invasive Bladder Cancer. Urology, 75, 1516.e9-13.
|
[30]
|
Kim, E.J., Yan, C., Ha, Y.S., Jeong, P., Yi Kim, I., Moon, S.K., Choi, Y.H. and Kim, W.J. (2012) Analysis of hOGG1 Genotype as a Prognostic Marker for Muscle Invasive Bladder Cancer: A Novel Approach Using Peptide Nucleic Acid-Mediated, Real-Time PCR Clamping. Urologic Oncology, 30, 673-679.
https://doi.org/10.1016/j.urolonc.2010.07.008
|
[31]
|
Ying, L., Huang, Y., Chen, H., Wang, Y., Xia, L., Chen, Y., Liu, Y. and Qiu, F. (2013) Downregulated MEG3 Activates Autophagy and Increases Cell Proliferation in Bladder Cancer. Molecular BioSystems, 9, 407-411.
https://doi.org/10.1039/c2mb25386k
|
[32]
|
Astuti, D., Latif, F., Wagner, K., Gentle, D., Cooper, W.N., Catchpoole, D., Grundy, R., Ferguson-Smith, A.C. and Maher, E.R. (2005) Epigenetic Alteration at the DLK1-GTL2 Imprinted Domain in Human Neoplasia: Analysis of Neuroblastoma, Phaeochromocytoma and Wilms’ Tumour. British Journal of Cancer, 92, 1574-1580.
https://doi.org/10.1038/sj.bjc.6602478
|